Abstract: An embodiment of a method and apparatus for ciphering data. Data is provided for ciphering. The data is ciphered in a plurality of steps. For each step, determining an encoding for error detection of the data being processed within the step. Determining an output error detection encoding for the step. Processing data of the round to provide output error detection encoding. Then, verifying the encoding against a determined output error detection encoding. If the output error detection encoding is not the same as the determined error detection encoding, providing a signal indicating the presence of an error within the cipher process.

Abstract: A novel method for human minor histocompatibility antigen (MiHA) discovery, novel MiHAs identified using this method, as well as uses of the novel MiHAs, are described. One of the features of the novel method is the inclusion of personalized translated transcriptome and/or exome in the database used for peptide identification by mass spectroscopy (MS). Candidate MiHAs are identified by comparing the personalized transcriptome and/or exome to a reference genome and/or to the transcriptome and/or exome of an HLA-matched subject.

Abstract: An embodiment of a method and apparatus for ciphering data. Data is provided for ciphering. The data is ciphered in a plurality of steps. For each step, determining an encoding for error detection of the data being processed within the step. Determining an output error detection encoding for the step. Processing data of the round to provide output error detection encoding. Then, verifying the encoding against a determined output error detection encoding. If the output error detection encoding is not the same as the determined error detection encoding, providing a signal indicating the presence of an error within the cipher process.

Abstract: A novel method for human minor histocompatibility antigen (MiHA) discovery, novel MiHAs identified using this method, as well as uses of the novel MiHAs, are described. One of the features of the novel method is the inclusion of personalized translated transcriptome and/or exome in the database used for peptide identification by mass spectroscopy (MS). Candidate MiHAs are identified by comparing the personalized transcriptome and/or exome to a reference genome and/or to the transcriptome and/or exome of an HLA-matched subject.

Abstract: What is disclosed is an embodiment of a method for ciphering data. Data is provided for ciphering thereof. The data is ciphered in a plurality of steps. For each step, an encoding for error detection of the data for being processed within the step is determined. An output error detection encoding for the step is determined. The data for being processed within the round is processed to provide output error detection encoding which is then verified against the determined output error detection encoding. When the output error detection encoding is other than same as the determined error detection encoding, providing a signal indicative of an error within the cipher process.

Abstract: A system and method for communicating data between a first software and a second software located on first and second devices, respectively, has a hardware driver and memory associated with each device. Each communication of data from the first software to the second software allocates memory to manage data to be communicated from the first software to the second software, provides memory allocation information to the hardware driver associated with the first software, and transmits the data from the first hardware driver to the second hardware driver for delivery to the second software via the memory associated with the second software.

Abstract: A secure generic encryption system for nonsecure datapaths comprises a format-specific adaptation layer/data path for receiving and processing nonsecure content data; an authentication engine located within a security perimeter and coupled to an external communication interface for authentication and supplying the format-specific adaptation layer/data path, located outside the security perimeter, with an output signal indicating whether authentication is successful; and a generic encryption module located within the security perimeter and coupled (1) to the authentication engine for receiving from the authentication engine initialization vectors, encryption keys, and the output signal indicating whether authentication is successful, and (2) to the format-specific adaptation layer/data path for (a) receiving a read signal from the format-specific adaptation layer/data path, and (b) providing the format-specific adaptation layer/data path with a data-available signal to indicate whether data is available to be

Abstract: A novel method for human minor histocompatibility antigen (MiHA) discovery, novel MiHAs identified using this method, as well as uses of the novel MiHAs, are described. One of the features of the novel method is the inclusion of personalized translated transcriptome and/or exome in the database used for peptide identification by mass spectroscopy (MS). Candidate MiHAs are identified by comparing the personalized transcriptome and/or exome to a reference genome and/or to the transcriptome and/or exome of an HLA-matched subject.

Abstract: What is disclosed is an embodiment of a method for ciphering data. Data is provided for ciphering thereof. The data is ciphered in a plurality of steps. For each step, an encoding for error detection of the data for being processed within the step is determined. An output error detection encoding for the step is determined. The data for being processed within the round is processed to provide output error detection encoding which is then verified against the determined output error detection encoding. When the output error detection encoding is other than same as the determined error detection encoding, providing a signal indicative of an error within the cipher process.

Abstract: Disclosed herein are substantially pure nucleic acids encoding mutated SUMO isoforms, polypeptides, vectors, cells and methods of their use to identify and quantify protein SUMOylation in mammalian cells. Also disclosed is a dual affinity method for detecting a mutated SUMOylated protein substrate fragment.

Abstract: Capacitive detector and measuring device integrating it; the detector including: a ribbon made of a dielectric material, first and second electrodes in the form of combs formed on a first surface of said ribbon and a third electrode formed on the other surface of said ribbon opposite said first and second electrodes; the thickness (e) of the dielectric ribbon is less than or equal to said determined period (?) divided by four times PI, i.e.: ?/4??e; and the ratio resulting from the division, as numerator, of the capacitance (C) between two adjacent branches of said first and second electrodes in the presence of at least one fluid with a dielectric permittivity (?f) and, as denominator, by the dielectric permittivity (?f) of the fluid multiplied by the capacitance (Co) between the two adjacent branches of the first and second electrodes in the presence of the vacuum is greater than or equal to one, i.e.: C/(?f*Co)?1. Method for manufacturing a detector fulfilling the above conditions.

Abstract: Disclosed herein are substantially pure nucleic acids encoding mutated SUMO isoforms, polypeptides, vectors, cells and methods of their use to identify and quantify protein SUMOylation in mammalian cells. Also disclosed is a dual affinity method for detecting a mutated SUMOylated protein substrate fragment.

Abstract: A pipe support which comprises a body having a recess of a generally U-shaped configuration formed therein, the recess being opened at a top end, the body having a clamping portion extending downwardly and which clamping portion includes first and second resilient members which each comprise a vertical sidewall and an inwardly extending end segment. The pipe support is particularly suitable for use on various structural members.

Abstract: Capacitive detector and measuring device integrating it; the detector including: a ribbon made of a dielectric material, first and second electrodes in the form of combs formed on a first surface of said ribbon and a third electrode formed on the other surface of said ribbon opposite said first and second electrodes; the thickness (e) of the dielectric ribbon is less than or equal to said determined period (?) divided by four times PI, i.e.: ?/4??e; and the ratio resulting from the division, as numerator, of the capacitance (C) between two adjacent branches of said first and second electrodes in the presence of at least one fluid with a dielectric permittivity (?f) and, as denominator, by the dielectric permittivity (?f) of the fluid multiplied by the capacitance (Co) between the two adjacent branches of the first and second electrodes in the presence of the vacuum is greater than or equal to one, i.e.: C/(?f*Co)?1. Method for manufacturing a detector fulfilling the above conditions.

Abstract: Surprisingly, the present inventors have discovered that expression of TAT-005 protein in human patients is associated with cancer, and that the over-expressed protein is present in plasma membrane fractions. Thus, the present inventors have discovered that TAT-005 is associated with abnormal development and growth, and may be useful as a target for the identification of anti-cancer com\ pounds, including antibodies for use in immunotherapy. Accordingly, the present invention provides methods for the identification of compounds that inhibit TAT-005 expression or activity, comprising: contacting a candidate compound with a TAT-005 and detecting the presence or absence of binding between said compound and said TAT-005, or detecting a change in TAT-005 expression or activity. Methods are also included for the identification of compounds that modulate TAT-005 expression or activity, comprising: administering a compound to a cell or cell population, and detecting a change in TAT-005 expression or activity.

Abstract: A pipe support assembly which comprises a main body having a U-shaped recess therein, and a cover member for the body, the cover member having an arcuate configuration and being sized to fit between the first and second side walls, each of the cover members and body having a channel or a recess designed to receive a tie wrap to secure a pipe in position. The main body portion also has a clamping portion which comprises first and second resilient members.

Abstract: A pipe support which comprises a body having a recess of a generally U-shaped configuration formed therein, the recess being opened at a top end, the body having a clamping portion extending downwardly and which clamping portion includes first and second resilient members which each comprise a vertical sidewall and an inwardly extending end segment. The pipe support is particularly suitable for use on various structural members.

Abstract: A pipe support assembly which comprises a main body having a U-shaped recess therein, and a cover member for the body, the cover member having an arcuate configuration and being sized to fit between the first and second side walls, each of the cover members and body having a channel or a recess designed to receive a tie wrap to secure a pipe in position. The main body portion also has a clamping portion which comprises first and second resilient members.

Abstract: A pipe support assembly which comprises a main body having a U-shaped recess therein, and a cover member for the body, the cover member having an arcuate configuration and being sized to fit between the first and second side walls, each of the cover members and body having a channel or a recess designed to receive a tie wrap to secure a pipe in position. The main body portion also has a clamping portion which comprises first and second resilient members.

Abstract: Surprisingly, the present inventors have discovered that expression of TAT-001 protein in human patients is associated with cancer, and that the overexpressed protein is present in plasma membrane fractions. Thus, the present inventors have discovered that TAT-001 is associated with abnormal development and growth, and may be useful as a target for the identification of anti-cancer compounds, including antibodies for use in immunotherapy. Accordingly, the present invention provides methods for the identification of compounds that inhibit TAT-001 expression or activity, comprising: contacting a candidate compound with a TAT-001 and detecting the presence or absence of binding between said compound and said TAT-001, or detecting a change in TAT-001 expression or activity.